SIX1, which has been reported to be involved in various cancer progressions and correlated with poor prognosis in breast cancer 30, acts as a tumour‐promoting factor by regulating c‐myc, cyclin‐D1 and cyclin‐A1. This evidence concerns the gene SIX1 and neoplasm.